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Background and objective. Resistance to antibiotics is a public health threat. A number of studies
confirm the relationship between antibiotic use and the resistance rate. As a whole, physicians
represent a large proportion of the health professionals involved in the use of this therapeutic
group. Our study therefore sought to ascertain the opinions and attitudes of GPs in Spain with
respect to antibiotics and resistance.
Methods. We used the focus group (FG) method, with each group comprising 4–12 primary care
physicians and a moderator. Based on a previous systematic review, we drew up an agenda to be
followed during the holding of the sessions. Group proceedings were recorded and the tran-
scriptions then analysed separately by two researchers.
Results. Five FGs were formed, including a total of 33 physicians. The factors/attitudes that influ-
enced the prescribing of antibiotics by GPs were fear, complacency, insufficient knowledge and
external responsibility of the pharmaceutical industry, patients and over-the-counter antibiotics.
The groups felt that antibiotic resistance was not a problem at a community level.
Conclusions. Identification of attitudes/knowledge related with inappropriate antibiotic prescrib-
ing will enable specific interventions to be designed, with the aim of targeting these shortcom-
ings to improve antibiotic use and help reduce resistance.
Keywords. Attitudes, antibiotic prescription, antimicrobial resistance, primary care physicians,
qualitative, Spain.
Background
Resistance to antibiotics is an important public health
threat, which is aggravated by the lack of development
of new antimicrobial agents.1,2 Currently, there are
few doubts as to the association between antibiotic
use and the spread of antimicrobial resistance. Ecolog-
ical studies undertaken as a result of European initia-
tives suggest that there is a clear association between
use of antibiotics (penicillins and fluoroquinolones)
and resistance rates.3 Moreover, there is a wide vari-
ability among countries, which is not justified by dif-
ferences in the prevalences of infectious disease.3,4
The use of antibiotics occurs mainly in primary
care:5,6 in the best-case scenario, non-hospital use
exceeds 10 defined daily doses per 1000 population-
day (DHD) versus hospital use of three DHDs. 4 In
the period 1997–2009, mean non-hospital antibiotic
use within the ambit of Spain’s National Health Sys-
tem (NHS) was 20.15 DHDs.7 These figures are higher
still if total antibiotic sales are taken into account
(a caption that also includes prescriptions by private
physicians and drugs dispensed without medical pre-
scription), which rose to 28.93 DHD in 2005 and
would rank Spain among the highest consuming coun-
tries.8 Compared with other European countries,
therefore, Spain displays elevated antimicrobial resis-
tance rates in community pathogens.9
In the light of the above situation, interest lies in
exploring the possible causes of inappropriate
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antibiotic use in Spain. Many factors have been linked to
inappropriate antibiotic use, 10–12 including insufficient
knowledge, patient pressure and the pharmaceutical in-
dustry. Furthermore, different actors are involved in this
inappropriate and excessive use of antimicrobials,
namely, physicians, patients, pharmacists and health au-
thorities. Since antibiotics are medications that can only
be sold under medical prescription in Spain, any action
aimed at improving the use of antimicrobials must nec-
essarily target physicians. Accordingly, our study sought
to ascertain GPs’ opinions on and attitudes to antibiotics
and resistance and discuss whether these differed from
those found in other countries with lower consumption
and resistance rates.
Methods
Study design
The focus group (FG) method was used to explore
GPs’ habits and knowledge with regard to antibiotics
and identify the attitudes and/or factors that influence
their being prescribed. We decided to use the FG
technique because the interaction of group members
tends to ensure that all the dimensions of the problem
assessed are brought to light, information is simulta-
neously obtained on the subjective validity of various
members of the group and in addition, it is a fast tech-
nique for generating such information. 13 A theoretical
model based on a previous systematic review was con-
structed for the purpose of drawing up an agenda,
which was to be followed during the group sessions to
facilitate the identification of attitudes and/or factors.
The categories defined for this agenda were (i) the
antibiotic prescribing process, (ii) practical consequen-
ces of misuse and (iii) recommendations for improving
drug use. The following three subcategories were in-
cluded under the first category: most frequent diseases
for which antibiotics were used, types of antibio-
tics most and least frequently used and attitudes/
factors that interfered in the prescription process. The
attitudes/factors covered by the systematic review and
included in the agenda were (i) fear/precaution, (b)
external responsibility, (c) complacency and (d) insuf-
ficient knowledge.
Study population and settings
The eligible population was made up of all GPs in the
Spanish NHS in Galicia, actively engaged in health
care during these months (3200 physicians). Galicia
is a region lying in the northwest of Spain, with an area
of 29 434 km 2 and a population of 2 794 516 million,
22.2% of which is aged >65 years. Practically, 100% of
the population is covered by the publicly funded NHS.
In Spain, medical drugs may only be dispensed by
community pharmacies, and in the case of antibiotics,
a medical prescription is moreover required.14
Selection of sample and procedure
The FG sessions were held in the provinces
of Pontevedra and A Corun ˜a (Corunna) in Galicia
(NW Spain), from April through June 2009. In Spain,
practically, 100% of the population is covered by the
NHS. With the support of the Galician Association of
Family & Community Medicine (Asociacio ´n Gallega
de Medicina Familiar y Comunitaria—AGAMFEC),
information on the research project was previously
circulated via the channels usually used by this associ-
ation, to foster professionals’ motivation and encour-
age them to participate in the FGs.
Based on key informants, 75 candidates were con-
tacted by telephone or e-mail, informed about the
study’s goal and invited to take part in the FGs. Finally,
33 physicians agreed to participate in the groups.
Holding of FGs
Each FG was made up of 4–10 GPs. Pediatricians also
took part in two cases (at those health centres selected
which had pediatrics departments). Of the total,
57.7% of the participants were men. The FGs were
guided by three of the researchers (JMVL, PLV and
ALD), who coordinated the participation of the group
members in line with a pre-established agenda (see
Appendix 1). With the aim of enhancing participation
of the professionals, FG sessions were held in the
meeting rooms of the respective health centres se-
lected, normally on the day and at the time reserved
by the center for teaching activities. In addition, each
participant was presented with a gift valued at V20.
Participants were informed that sound recordings
would be made of the sessions, that the confidentiality
of all content would be respected and that in no case,
would comments be identified with any particular par-
ticipant. In every group, the written consent of all the
participants was obtained. The study was evaluated
and approved by the Galician Clinical Research Ethics
Committee.
Group sessions were recorded using a digital re-
corder, lasted 60–90 minutes and were brought to an
end when the information furnished by the partici-
pants provided no new ideas. Participants were coded
according to gender (M, man and W, woman) and the
serial number of the FG (FG1, FG2, etc.). To prevent
any possible interpretation biases, the proceedings
were transcribed by an independent researcher (MTT).
Analysis
Once the literal transcription of the recordings of all
the FGs had been completed, and following successive
readings, we made a note of the different ideas, which
had emerged in the group discussions and might be
of use in the subsequent stages of the analysis. To this
end, paragraphs containing relevant information were
identified according to the categories predefined for
the purpose of attaining the study’ goals. This was
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done by an independent peer review conducted by two
members of the research team (JMVL and ALD), to
ascertain what degree of discrepancy might be en-
tailed in interpreting physicians’ opinions to associate
them with a specific attitude.
A computerized format was not used to process the
results, in view of the fact that the utility of specific
statistical programs is directed at analyses involving
a large number of interviews, which was not the case
in our study.
Results
Five FGs were formed at five health centres in the
Galician Autonomous Region. A total of 33 primary
care physicians were interviewed, 14 women (42.4%)
and 19 men (57.6%).
Antibiotic prescribing process
The first item on the agenda was to ascertain the
diseases for which antibiotics were most frequently
prescribed. All the FGs concluded that these were
respiratory diseases and upper respiratory tract infec-
tions in particular. They indicated that, within this
group, the use of antibiotics was particularly frequent
in exacerbations of chronic obstructive pulmonary dis-
ease (COPD). This category was followed by urinary
and dermatologic infections and others which, albeit
of less quantitative relevance, were nevertheless very
characteristic, such as otitis media in children and the
topical use of antibiotics in conjunctivitis.
Insofar, as the most frequently used types of antibiot-
ics were concerned, beta-lactams (specifically, amoxi-
cillin) ranked first, followed by macrolides, topical
aminoglycosidesand fluoroquinolones. In the case of
the least prescribed, participants cited cephalosporins,
tetracyclines (because they are only used in acne), eryth-
romycin, clarithromycin and, in general, antibiotics that
were very novel and those that had more side-effects.
With respect to the factors that influenced the
choice of antibiotic, participants indicated that they
were guided, firstly: by the patient’s clinical profile,
i.e. ‘I pay a lot of attention to the appearance of the
secretions; if they’re white or transparent, I view it as
most likely being viral; if they look greenish, I view
it as most likely being bacterial’ (M1 FG4); by their
own professional experience; by the recommendations
laid own by the clinical guidelines, ‘It’s good to have a
guideline but it must be adapted to the local situation’
(M1 FG4) and by the price of the drug. Furthermore,
they pointed out that pharmaceutical companies ex-
erted an influence when it came to choosing between
one antibiotic and another: ‘The influence of the phar-
maceutical industry is so clear that, when they stop
promoting a medication, then, in the long term, you
too stop using it’ (M1 FG5).
They considered that the factors influencing the pre-
scription of antibiotics were (see Table 1):
1. fear: ‘Among people with heart failure, with
COPD, you can’t say, well let’s see if it turns out to
be viral and not give the patient anything. Sometimes
one has to attack and that’s all there’s to it [. . . ] be-
cause that way, in 8 days you’ve got the problem
solved, and if you leave it any longer then maybe you
have to hospitalize the patient’ (W2 FG1); ‘The
patient’s already come to see you three times . . .
I think it’s viral, but well, well the fact is, it is viral
but it seems that it may re-infect, or who knows, for
your own peace of mind, for the patient’s peace of
mind, and then, when he’s already been to see you
three times, hey, and he’s been suffering from what-
ever it is for 10 days, then even though you initially
thought it was viral, well then, well you give him
a course of antibiotics, it’s true’ (M2 FG2).
2. External responsibility, whether of the: patient,
‘We aren’t to blame; it’s the patients who don’t take
the medication when you give it to them’ (M1 FG1);
pharmacies, ‘They still dispense antibiotics without
a prescription at the pharmacies [. . . ] then they come
to you with the receipt so that you give them the pre-
scription’ (W1 FG5) or pharmaceutical companies,
‘We are constantly being bombarded by the pharma-
ceutical industry because they keep on saying that this
is the latest cephalosporin, the best, the one that’s
recommended in all the guidelines for the treatment of
increased expectoration in COPD, and it’s a lie; and so
that’s what we have to fight against, [. . . ]’ (M4 FG2).
3. complacency: ‘I’ve seen children who come with
a virosis for which they don’t need an antibiotic but as
they’re not satisfied, they go and see a private doctor’
(W4 FG1); ‘The fact is that if I don’t prescribe them
something, they’ll go to another physician so that he’ll
prescribe it for them’ (W2 FG4).
4. lack of information on the part of the physician:
‘The fact of the matter is that there’s the problem that
physicians and patients believe in this (antimicrobials),
so . . . it’s a problem, it’s a habit, and habits are very
hard to break’ (M1 FG3).
Practical consequences of misuse
Do you stop to think a lot about bacterial resis-
tance when it comes to practising routine medi-
cine? No (M1 FG1).
Most of the FG members perceived resistance as be-
ing unimportant in upper respiratory tract infections
but important in urinary infections. In addition, they
considered resistance as being a problem at a hospital
rather than at a community level, and attributed such
antibiotic resistance to patients’ non-compliance with
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treatment, drugs being dispensed without medical pre-
scription and the volume of inappropriate prescrip-
tions being issued by other professional groups in
general and by dentists, community pharmacists and
the veterinary industry in particular.
Recommendations for improving drug use
Finally, we sought to record proposals for improving
antibiotic use (see Table 2). Among these, great
stress was laid on: the need for better access to
diagnostic tests [such as the rapid strep test and C-
reactive protein test], ‘What we miss is having far
more tests, far more rapid analyses for taking deci-
sions based on a certain degree of evidence’(W2
FG4); access to patients’ e-histories; better popula-
tion education to avoid pressure to prescribe
these drugs, ‘Patient education is fundamental, as is
a good physician-patient relationship’ (M3 FG4),
‘What has to be done is to educate people, so that
they know when it is and when it isn’t necessary to
go the doctor’ (M2 FG3); having a health profes-
sional available at a hospital level for expert consul-
tation on possible doubts and continuous medical
education.
TABLE 1 Conclusions of the five FGs regarding the tools for ascertaining type of infection involved, factors affecting antibiotic administration and
resistance
FG I FG II FG III FG IV FG V
How do physicians
differentiate
between viral and
bacterial infection?
Rapid diagnostic
tests
Rapid diagnostic
tests
Based on clinical
profile
Based on experience Based on clinical
profile
Based on experience Use of delayed
prescribing
Supplementary tests Use of clinical
guidelines
Rapid diagnostic
tests
Based on clinical
profile
Use of clinical
guidelines
Factors that
influence antibiotic
use
Fear due to patient
characteristics
Complacency Complacency External
responsibility of
pharmacies
Fear due to negative
disease progress
Complacency External
responsibility of
pharmacies
External
responsibility of
patient
External
responsibility of
health care system
Concern due to lack
of patient follow-up
External
responsibility of
patient
Fear due to patient
characteristics
External
responsibility of
pharmacies
Concern due to lack
of patient follow-up
Insufficient
knowledge
External
responsibility of
pharmacies
Insufficient
knowledge
Fear due to
physicians’ lack of
confidence
External
responsibility of
pharmaceutical
companies
External
responsibility of
health care system
Complacency External
responsibility of
pharmaceutical
companies
Fear due to negative
disease progress
External
responsibility of
other professionals
External
responsibility of
laboratories
Complacency
Concern due to lack
of patient follow-up
in medical
emergencies
External
responsibility of
health care system
Fear due to patient
characteristics
Fear due to patient
characteristics
Fear due to patient
characteristics
Resistance It is a problem at
a hospital level
No resistance
discerned, except in
some cases of
urinary infection
The issue has been
exaggerated
Discerned above all
in urinary infections
(less so in
respiratory
infections)
Resistance is
frequent in urinary
and respiratory
infections
No resistance
discerned, except in
urinary infections.
Resistance is
a problem in routine
clinical practice.
It does not affect
them in their work
It is a problem at
a hospital level
Treatment non-
compliance, hospital
treatments, drugs
dispensed without
prescription and
dentists are to blame
Caused by patients’
non-compliance with
prescription and
excessive use at
a hospital level
Prolonged use of
antibiotics facilitates
appearance of
resistance
Dentists and misuse
by patients are to
blame
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Discussion
Principal findings
In this first Spanish qualitative study to explore
GPs’ opinions about and attitudes to antibiotics and
antimicrobial resistance, the factors that influenced
prescribing were found to be fear, complacency, insuf-
ficient knowledge and external responsibility. GPs per-
ceived upper respiratory tract infections as the
principal disease for which they prescribed most anti-
biotics and beta-lactams as the most frequently pre-
scribed antimicrobials.
Comparison with literature
The physicians in all five groups agreed on the fact
that the disease for which they prescribed most antibi-
otics was acute upper respiratory tract infection, which
includes otitis, sinusitis, pharyngitis, tonsillitis and
bronchitis. This opinion is confirmed by several stud-
ies.15 The most frequent of such infections is pharyngi-
tis/tonsillitis, conditions that cause a sore throat,
symptoms which, according to a number of studies,
generate the greatest volume of consultations in pri-
mary care16,17 and for which avoidance of inappropri-
ate antibiotic prescribing has been recommended.18
This category is followed by urinary infections, a find-
ing in line with previous studies. 15
Among the groups and antibiotics cited by partici-
pants as being the most prescribed in primary care,
are beta-lactams, followed by macrolides, a finding
that agrees both with the conclusions of the European
Surveillance of Antimicrobial Consumption (ESAC) 4
and with the recommendations of the various antibi-
otic prescription guidelines used in primary care. 18–20
There is wide variability in antibiotic prescribing in
Europe,21 something that cannot be accounted for by
differences in morbidity.
With reference to appropriate antibiotic use, the
participants in the five groups stated that one of
the greatest difficulties was posed by uncertainty in
the etiological diagnosis, an aspect that characterizes
the management of these disorders. As possible
solutions for overcoming this uncertainty, they pro-
posed some initiatives, such as greater access to rapid
diagnostic tests (which are not yet available at some
health centres in Galicia) or the use of clinical guide-
lines. It has been shown that access to rapid diagnostic
tests improves antibiotic prescribing22 and that render-
ing clinical guidelines more readily manageable in
a consultation setting can be useful for reducing inap-
propriate prescription of such drugs.23 Other factors that
have also been shown to help reduce this uncertainty
are the physician’s clinical experience and knowledge
of the patient.24 One group made mention of the option
of delayed antibiotic prescribing as a intermediate solu-
tion in doubtful cases but argued that this measure was
not yet widely implemented in Spain.24,25
In particular, participants identified resistance at
a urinary infection level, something that is in agree-
ment with the data yielded by a number of reports on
the situation in Spain. 26,27 Even so, it should be noted
that most of those interviewed felt that the issue of
resistance did not significantly affect them in their
work and that it was a problem mainly at a hospital
level. Indeed, only one of the groups made the point
that resistance was a problem in daily clinical practice
and was frequent in urinary and respiratory infections.
Perhaps,this perception may be explained by the fact
that resistant cases tend to be followed up in a hospital
setting, and this gives a false impression of the non-
existence of resistance. These data are in line with those
obtained from a study similar to ours conducted in the
UK. 28 Such opinions should give cause for reflection as
to whether national campaigns undertaken in different
countries in the Europe or USA are really effective,
seeing as the physician, the very person bearing the sin-
gle greatest responsibility for prescribing, does not seem
to have perceived the importance of resistance and its
link to inappropriate use. One option for alerting the
members of this group to the importance of resistance
would be for regular reports to be issued on any resis-
tance encountered in isolations performed in their geo-
graphic setting. This could be a way of ensuring, at this
level, that sight was not lost of this problem.
Insofar, as the attitudes that influence antibiotic pre-
scribing in primary care were concerned, fear and
complacency were confirmed, in line with other stud-
ies.29–32 In our study, we sought to conduct an in-depth
examination of the processes generated by these atti-
tudes. In all groups, the principal causes that gave rise
to an attitude of fear/precaution and culminated
in the prescribing of an antibiotic were shown to be:
TABLE 2 Recommendations proposed by the different FGs to
improve antibiotic use
Recommendations No. of times
mentioned
Better population education 2
Greater access to diagnostic tests 5
Enhanced degree of communication between
primary and secondary health care levels
1
Transfer of chronic patients to primary care 1
Total access to patients’ e-histories (particularly in
emergencies)
3
Continuous medical education 2
Availability of a professional at a hospital level for
expert consultation and discussion
2
Clinical guidelines to be used as a reference but not
interpreted literally
1
Use of delayed prescribing 2
Availability of a map of local resistance 2
Regular meetings with primary care pharmacy or
local area management to gain a more accurate idea
of their respective prescription profiles and so
pinpoint what they might be doing wrong
1
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comorbidity (COPD, advanced age and other risk fac-
tors), non-satisfactory clinical progress and envisaged
difficulty of follow-up. Our area is characterized by
the high percentage of the population aged >65 years
and the wide degree to which the population is dis-
persed, factors which could serve to exacerbate physi-
cians’ fear of complications. With respect to this latter
case, special mention was made of the management of
unknown patients (e.g. those who were seen in emer-
gency wards or who came from other physicians). In
such instances,faced with the fear that complications
might set in and the difficulty of following up disease
progress,practitioners tend to prescribe an antibiotic,
even though its indication may well be questionable.
The principal cause that induces the attitude of compla-
cency is the pressure explicitly or implicitly exerted by
the patient to have an antibiotic prescribed. This attitude
is constantly repeated in most of the studies addressing
the prescription process.31,33,34The options for combat-
ing these attitudes are, in some cases, difficult to tackle,
such as ensuring that all the patients are consulted and
followed up by their usual physician. However, the use
of delayed prescribing and the dissemination of this con-
cept among the population to facilitate acceptance could
be an excellent weapon for eliminating physicians’ fear
of non-immediate prescribing of antibiotics in doubtful
cases.24,25
Another of the causes mentioned, and one that is
featured less prominently in studies on this topic, is
the attitude of external responsibility. Physicians lay
the blame for inappropriate use of antibiotics on
other professionals, such as dentists, community
pharmacists, veterinary surgeons or pharmaceutical
companies. With respect to the first group, studies on
prescribing in Spain confirm that the oral bacteria
most frequently implicated in odontogenic infection
display increased resistance to the action of the most
usual antibiotics. 35,36 An increase has thus been de-
tected in resistance to macrolides, beta-lactams and
clindamycin in strains of both Streptoccocus viridans
and Porphyromona, Prevotella spp and Fusobacte-
rium spp, producers of beta-lactamase isolated in the
buccal cavity.37–40 Similar results have been reported
by studies undertaken in pharmacies, where a rela-
tionship has been observed between the dispensing
of antibiotics without prescription and the genesis of
resistance.10,41,42Although by law antibiotics may on-
ly be dispensed in Spain on presentation of a medical
prescription, the reality is that dispensing drugs with-
out a prescription is still common practice. Indeed,
one study undertaken in this country established that
as many as 65.9% of pharmacists dispensed amoxicillin
to their pharmacy’s regular customers, a percentage
that fell to 40.9% when it came to supplying those who
were not regular customers.14 The data also seem to
confirm that the veterinary industry may have some-
thing to do with the increase in resistance.43,44
With respect to pharmaceutical companies, while in
Spain, it is the norm for pharmaceutical sales repre-
sentatives to visit physicians to present their products,
and this has often been regarded as a factor associated
with inappropriate prescribing; 45 in the case of our
study, it is noteworthy that this was only mentioned
by two of the groups.
Strengths and weaknesses
This study has the limitations and strengths peculiar to
the use of qualitative methodology. Among its limita-
tions is the low number and source of the participants
(health professionals drawn from a specific area of
Spain, who are not necessarily representative of all
primary care physicians in the employ of Spain’s
NHS), something that restricts the study’s generaliza-
tion to other areas or countries. Among the study’s ad-
vantages is the fact that the interaction which typically
takes place among the members of a FG, enabled
ideas on antibiotics and resistance to be obtained,
which would otherwise have been difficult to obtain
without such interaction. 46–48
A systematic review of quantitative studies was re-
cently published, addressing the factors associated with
inappropriate prescribing of antibiotics. Although the
authors of the review indicate that most of the studies
display very important methodological limitations which
determine the grade of evidence of their conclusions, the
review nevertheless concludes that there seem to be two
attitudes, namely, fear and complacency, which are asso-
ciated with misprescription of antibiotics.49 Our study’s
qualitative approach enabled one more attitude to be
detected, i.e. external responsibility (essentially with ref-
erence to pharmacists), something that reaffirms the use-
fulness of qualitative methodology.
Implications for practice and research
Inappropriate antibiotic prescribing at a non-hospital
level is one of the causes of the resistant germ emer-
gency. It appears that the attitudes, which mainly lead
to inappropriate prescribing are fear of complications,
complacency vis-a`-vis patient pressure, and insufficient
knowledge. Using a well-designed quantitative study,
it would be pertinent to assess whether such attitudes/
knowledge were associated with the quality and quan-
tity of antibiotic prescribing. Once the attitudes and/
or knowledge associated with inappropriate prescrib-
ing were identified in this way, specific interventions
focusing on these shortcomings could then be designed
to improve the use of antimicrobials and contribute to
reducing resistance.50
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A PPENDIX 1 Qualitative approach to GPs’ attitudes and knowledge which influence
inappropriate antibiotic prescribing
Objective
The study’s aim is to ascertain why GPs who work in the primary care setting of the Galician Health Service pre-
scribe antibiotics inappropriately.
Design
- Data-collection technique: FGs
- Type of sampling: Theoretical. Bearing the scientific literature on the subject in mind, there is evidence to
show that medical internship training (‘Me ´dico Interno Residente—MIR’) can influence physicians’ prescrib-
ing. We feel that the workplace could also influence prescribing. We shall try and create two groups per struc-
tural segment (specialization via or not via MIR and rural or urban work setting) defined so as to ensure that
results obtained in one are ratified in another (‘saturation’ of information).
- Sampling units: All GPs who work in primary care in the Galician Health Service (‘Servizo Galego de
Sau´de—SERGAS’).
- Participant selection method: Snowball method, based on key informants who facilitate contact with other
physicians,taking the variable of segmentation into account, i.e. specialization via MIR, specialization other
than via MIR, urban health centre and rural health centre. Possible candidates will be contacted by telephone
or e-mail and invited to collaborate. With the support of the Galician Association of Family & Community
Medicine (‘Asociacio´ n Gallega de Medicina Familiar y Comunitaria—AGAMFEC’), information on the re-
search project will be previously circulated, via the channels usually used by this association, to foster participa-
tion both at this and at subsequent stages. One week before holding the respective group sessions, participants
will be recontacted to confirm their attendance.
- Place and date of group sessions: In view of the designated study objectives (determinants of prescribing),
group sessions will preferably be held at venues unconnected with the Galician Health Service, to ensure that
the study is in all cases kept separate from the health authority. Group venues and timetables will be tailored
to the needs of the final participants.
- Duration: 1 hour.
- Ethical aspects:Prior to the commencement of group sessions, participants will be asked to give their in-
formed consent to the proceedings being recorded.
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Structure of FG discussion content
A. Prescription process in respiratory infections.
For which diseases do you frequently prescribe antibiotics? (Ignorance)
Which antibiotics do you use most? Why? (Ignorance)
Which do you hardly use? Why? (Ignorance)
*And penicillin, it continues to appear in all the guidelines and is hardly ever prescribed in primary care: to what
do you feel this is due?
*Which data sources do you use to bring yourself up to date on the treatment of respiratory infections?: industry,
colleagues, clinical guidelines, administration . . .?
What criteria do you use to diagnose infections of bacterial aetiology? (external factors associated with patients)
*Which symptoms or signs lead you to consider the need to prescribe an antimicrobial?
*Is the patient’s clinical history important in the treatment of this type of infection? Is the patient’s age important
when it comes to prescribing an antibiotic?
*Do you evaluate other non-clinical factors, such as sociofamilial situation (multipathology and elderly patients in
the family), for prescribing an antimicrobial?
What barriers do you come up against at the time of diagnosis? (external factors associated with industry)
*What in your opinion is the role played by lack of access to supplementary tests?
*What do you feel influences the lack of time for assessing and following up patients’ compliance with prescrip-
tions? *and the excessive number of patients?
*Do you think industry influences the prescribing of antimicrobials in primary care? Industry
There are other factors that may influence us in antibiotic prescribing, for example:
*Sometimes the diagnosis is not definitive and it is preferable to prescribe, lest the case become complicated and
turn into in pneumonia. Fear
*What influence do certain characteristics of the patient have, such as his/her occupational status, the fact of living
far from the health centre and having difficulties in getting there . . . (individual patient’s well-being versus public
health).
*And the patients?: do they put pressure on you to prescribe antimicrobials, e.g. occupational status, imminent
travel plans. (Complacency)
B. Practical consequences of misuse: resistance:
In practice, do you believe that there are consequences of inappropriate antimicrobial prescribing? Indifference
*Does it seem to you that resistance tends to be more of an intangible issue, for the attention of specialists, but
has no influence on routine medical practice.
*How do you perceive the problem of resistance in your setting? Have you had any negative experience with resis-
tance?
Do you believe in the discovery of new antibiotics with an improved profile and that these will replace existing
ones with a high resistance rate? Faith in innovation
Do you have information on the resistance rate in your area? Do you think that this would be of use to you? Igno-
rance
What do you think are the causes of resistance? External responsibility
*Hospital prescription? Which specialists are the worst prescribers?
*Dispensing without medical prescription at
pharmacies?
*Misuse by patients?
*Indiscriminate use in veterinary medicine?
*Is it possible that there might be other causes?
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